ID   ANGT_HUMAN              Reviewed;         485 AA.
AC   P01019; Q16358; Q16359; Q96F91;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   10-MAY-2017, entry version 205.
DE   RecName: Full=Angiotensinogen;
DE   AltName: Full=Serpin A8;
DE   Contains:
DE     RecName: Full=Angiotensin-1;
DE     AltName: Full=Angiotensin 1-10;
DE     AltName: Full=Angiotensin I;
DE              Short=Ang I;
DE   Contains:
DE     RecName: Full=Angiotensin-2;
DE     AltName: Full=Angiotensin 1-8;
DE     AltName: Full=Angiotensin II;
DE              Short=Ang II;
DE   Contains:
DE     RecName: Full=Angiotensin-3;
DE     AltName: Full=Angiotensin 2-8;
DE     AltName: Full=Angiotensin III;
DE              Short=Ang III;
DE     AltName: Full=Des-Asp[1]-angiotensin II;
DE   Contains:
DE     RecName: Full=Angiotensin-4;
DE     AltName: Full=Angiotensin 3-8;
DE     AltName: Full=Angiotensin IV;
DE              Short=Ang IV;
DE   Contains:
DE     RecName: Full=Angiotensin 1-9;
DE   Contains:
DE     RecName: Full=Angiotensin 1-7;
DE   Contains:
DE     RecName: Full=Angiotensin 1-5;
DE   Contains:
DE     RecName: Full=Angiotensin 1-4;
DE   Flags: Precursor;
GN   Name=AGT; Synonyms=SERPINA8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=6089875; DOI=10.1021/bi00311a006;
RA   Kageyama R., Ohkubo H., Nakanishi S.;
RT   "Primary structure of human preangiotensinogen deduced from the cloned
RT   cDNA sequence.";
RL   Biochemistry 23:3603-3609(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2924688; DOI=10.1089/dna.1.1989.8.87;
RA   Gaillard I., Clauser E., Corvol P.;
RT   "Structure of human angiotensinogen gene.";
RL   DNA 8:87-99(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1692023;
RA   Fukamizu A., Takahashi S., Seo M.S., Tada M., Tanimoto K., Uehara S.,
RA   Murakami K.;
RT   "Structure and expression of the human angiotensinogen gene.
RT   Identification of a unique and highly active promoter.";
RL   J. Biol. Chem. 265:7576-7582(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-335.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-338.
RX   PubMed=2885106; DOI=10.1161/01.RES.60.5.786;
RA   Kunapuli S.P., Kumar A.;
RT   "Molecular cloning of human angiotensinogen cDNA and evidence for the
RT   presence of its mRNA in rat heart.";
RL   Circ. Res. 60:786-790(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-184.
RX   PubMed=3579322; DOI=10.1016/0003-9861(87)90148-2;
RA   Kunapuli S.P., Benedict C.R., Kumar A.;
RT   "Tissue specific hormonal regulation of the rat angiotensinogen gene
RT   expression.";
RL   Arch. Biochem. Biophys. 254:642-646(1987).
RN   [7]
RP   PROTEIN SEQUENCE OF 34-58.
RX   PubMed=7259779; DOI=10.1016/0006-291X(81)90762-2;
RA   Tewksbury D.A., Dart R.A., Travis J.;
RT   "The amino terminal amino acid sequence of human angiotensinogen.";
RL   Biochem. Biophys. Res. Commun. 99:1311-1315(1981).
RN   [8]
RP   PROTEIN SEQUENCE OF 34-45, AND SUBUNIT.
RC   TISSUE=Serum;
RX   PubMed=7539791; DOI=10.1074/jbc.270.23.13645;
RA   Oxvig C., Haaning J., Kristensen L., Wagner J.M., Rubin I.,
RA   Stigbrand T., Gleich G.J., Sottrup-Jensen L.;
RT   "Identification of angiotensinogen and complement C3dg as novel
RT   proteins binding the proform of eosinophil major basic protein in
RT   human pregnancy serum and plasma.";
RL   J. Biol. Chem. 270:13645-13651(1995).
RN   [9]
RP   PROTEIN SEQUENCE OF 34-43.
RX   PubMed=4300938;
RA   Arakawa K., Minohara A., Yamada J., Nakamura M.;
RT   "Enzymatic degradation and electrophoresis of human angiotensin I.";
RL   Biochim. Biophys. Acta 168:106-112(1968).
RN   [10]
RP   GLYCOSYLATION AT ASN-47; ASN-170; ASN-304 AND ASN-328.
RX   PubMed=3934016; DOI=10.1016/0303-7207(85)90039-5;
RA   Campbell D.J., Bouhnik J., Coezy E., Menard J., Corvol P.;
RT   "Processing of rat and human angiotensinogen precursors by microsomal
RT   membranes.";
RL   Mol. Cell. Endocrinol. 43:31-40(1985).
RN   [11]
RP   FUNCTION OF ANGIOTENSIN-3.
RX   PubMed=1132082; DOI=10.1161/01.RES.36.6.38;
RA   Goodfriend T.L., Peach M.J.;
RT   "Angiotensin III: (DES-Aspartic Acid-1)-Angiotensin II. Evidence and
RT   speculation for its role as an important agonist in the renin -
RT   angiotensin system.";
RL   Circ. Res. 36:38-48(1975).
RN   [12]
RP   FUNCTION OF ANGIOTENSIN-2.
RX   PubMed=10619573; DOI=10.1016/S0895-7061(99)00103-X;
RA   Weir M.R., Dzau V.J.;
RT   "The renin-angiotensin-aldosterone system: a specific target for
RT   hypertension management.";
RL   Am. J. Hypertens. 12:205S-213S(1999).
RN   [13]
RP   CLEAVAGE BY ACE AND ACE2.
RX   PubMed=10969042; DOI=10.1161/01.RES.87.5.e1;
RA   Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M.,
RA   Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R.,
RA   Breitbart R.E., Acton S.;
RT   "A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2)
RT   converts angiotensin I to angiotensin 1-9.";
RL   Circ. Res. 87:E1-E9(2000).
RN   [14]
RP   CLEAVAGE OF ANGIOTENSIN-1 AND ANGIOTENSIN-2 BY ACE2.
RX   PubMed=11815627; DOI=10.1074/jbc.M200581200;
RA   Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J.,
RA   Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M.A.,
RA   Nichols A., Tummino P.;
RT   "Hydrolysis of biological peptides by human angiotensin-converting
RT   enzyme-related carboxypeptidase.";
RL   J. Biol. Chem. 277:14838-14843(2002).
RN   [15]
RP   ANGIOTENSIN PEPTIDES METABOLISM.
RX   PubMed=15283675; DOI=10.1042/BJ20040634;
RA   Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M.;
RT   "Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2
RT   and neprilysin in angiotensin peptide metabolism.";
RL   Biochem. J. 383:45-51(2004).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-47.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [17]
RP   DECARBOXYLATION AT ASP-34, FUNCTION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17138938; DOI=10.1161/01.ATV.0000253889.09765.5f;
RA   Jankowski V., Vanholder R., van der Giet M., Tolle M., Karadogan S.,
RA   Gobom J., Furkert J., Oksche A., Krause E., Tran T.N., Tepel M.,
RA   Schuchardt M., Schluter H., Wiedon A., Beyermann M., Bader M.,
RA   Todiras M., Zidek W., Jankowski J.;
RT   "Mass-spectrometric identification of a novel angiotensin peptide in
RT   human plasma.";
RL   Arterioscler. Thromb. Vasc. Biol. 27:297-302(2007).
RN   [18]
RP   REVIEW ON THE RENIN-ANGIOTENSIN SYSTEM.
RX   PubMed=18793332; DOI=10.1111/j.1365-2796.2008.01981.x;
RA   Fyhrquist F., Saijonmaa O.;
RT   "Renin-angiotensin system revisited.";
RL   J. Intern. Med. 264:224-236(2008).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-47.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   STRUCTURE BY NMR OF ANGIOTENSIN-2.
RX   PubMed=9492317; DOI=10.1046/j.1432-1327.1998.2510448.x;
RA   Carpenter K.A., Wilkes B.C., Schiller P.W.;
RT   "The octapeptide angiotensin II adopts a well-defined structure in a
RT   phospholipid environment.";
RL   Eur. J. Biochem. 251:448-453(1998).
RN   [23]
RP   STRUCTURE BY NMR OF 34-43, AND STRUCTURE BY NMR OF 34-41.
RX   PubMed=12752436; DOI=10.1046/j.1432-1033.2003.03573.x;
RA   Spyroulias G.A., Nikolakopoulou P., Tzakos A., Gerothanassis I.P.,
RA   Magafa V., Manessi-Zoupa E., Cordopatis P.;
RT   "Comparison of the solution structures of angiotensin I & II.
RT   Implication for structure-function relationship.";
RL   Eur. J. Biochem. 270:2163-2173(2003).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (4.33 ANGSTROMS) OF 34-485 IN COMPLEX WITH
RP   RENIN, AND DISULFIDE BOND.
RX   PubMed=20927107; DOI=10.1038/nature09505;
RA   Zhou A., Carrell R.W., Murphy M.P., Wei Z., Yan Y., Stanley P.L.,
RA   Stein P.E., Broughton Pipkin F., Read R.J.;
RT   "A redox switch in angiotensinogen modulates angiotensin release.";
RL   Nature 468:108-111(2010).
RN   [25]
RP   VARIANTS MET-207; THR-268 AND CYS-281.
RX   PubMed=1394429; DOI=10.1016/0092-8674(92)90275-H;
RA   Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P.,
RA   Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R.,
RA   Lalouel J.-M., Corvol P.;
RT   "Molecular basis of human hypertension: role of angiotensinogen.";
RL   Cell 71:169-180(1992).
RN   [26]
RP   VARIANT THR-268.
RX   PubMed=8513325; DOI=10.1038/ng0593-59;
RA   Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C.,
RA   Farrington P.F., Ogasawara M., Suzumori K., Tomoda S., Berrebi S.,
RA   Sasaki M., Corvol P., Lifton R.P., Lalouel J.-M.;
RT   "A molecular variant of angiotensinogen associated with
RT   preeclampsia.";
RL   Nat. Genet. 4:59-61(1993).
RN   [27]
RP   VARIANTS ILE-242; ARG-244 AND CYS-281.
RX   PubMed=7607642; DOI=10.1007/BF00214197;
RA   Hixson J.E., Powers P.K.;
RT   "Detection and characterization of new mutations in the human
RT   angiotensinogen gene (AGT).";
RL   Hum. Genet. 96:110-112(1995).
RN   [28]
RP   VARIANT PHE-43.
RX   PubMed=7744780; DOI=10.1074/jbc.270.19.11430;
RA   Inoue I., Rohrwasser A., Helin C., Jeunemaitre X., Crain P.,
RA   Bohlender J., Lifton R.P., Corvol P., Ward K., Lalouel J.-M.;
RT   "A mutation of angiotensinogen in a patient with preeclampsia leads to
RT   altered kinetics of the renin-angiotensin system.";
RL   J. Biol. Chem. 270:11430-11436(1995).
RN   [29]
RP   CHARACTERIZATION OF VARIANT CYS-281.
RX   PubMed=8621667; DOI=10.1074/jbc.271.16.9838;
RA   Gimenez-Roqueplo A.P., Leconte I., Cohen P., Simon D., Guyene T.T.,
RA   Celerier J., Pau B., Corvol P., Clauser E., Jeunemaitre X.;
RT   "The natural mutation Y248C of human angiotensinogen leads to abnormal
RT   glycosylation and altered immunological recognition of the protein.";
RL   J. Biol. Chem. 271:9838-9844(1996).
RN   [30]
RP   VARIANT RTD GLN-375.
RX   PubMed=16116425; DOI=10.1038/ng1623;
RA   Gribouval O., Gonzales M., Neuhaus T., Aziza J., Bieth E., Laurent N.,
RA   Bouton J.M., Feuillet F., Makni S., Ben Amar H., Laube G.,
RA   Delezoide A.-L., Bouvier R., Dijoud F., Ollagnon-Roman E., Roume J.,
RA   Joubert M., Antignac C., Gubler M.-C.;
RT   "Mutations in genes in the renin-angiotensin system are associated
RT   with autosomal recessive renal tubular dysgenesis.";
RL   Nat. Genet. 37:964-968(2005).
CC   -!- FUNCTION: Essential component of the renin-angiotensin system
CC       (RAS), a potent regulator of blood pressure, body fluid and
CC       electrolyte homeostasis.
CC   -!- FUNCTION: Angiotensin-2: acts directly on vascular smooth muscle
CC       as a potent vasoconstrictor, affects cardiac contractility and
CC       heart rate through its action on the sympathetic nervous system,
CC       and alters renal sodium and water absorption through its ability
CC       to stimulate the zona glomerulosa cells of the adrenal cortex to
CC       synthesize and secrete aldosterone.
CC   -!- FUNCTION: Angiotensin-3: stimulates aldosterone release.
CC   -!- FUNCTION: Angiotensin 1-7: is a ligand for the G-protein coupled
CC       receptor MAS1. Has vasodilator and antidiuretic effects. Has an
CC       antithrombotic effect that involves MAS1-mediated release of
CC       nitric oxide from platelets. {ECO:0000250,
CC       ECO:0000269|PubMed:10619573, ECO:0000269|PubMed:1132082,
CC       ECO:0000269|PubMed:17138938}.
CC   -!- SUBUNIT: During pregnancy, exists as a disulfide-linked 2:2
CC       heterotetramer with the proform of PRG2 and as a complex (probably
CC       a 2:2:2 heterohexamer) with pro-PRG2 and C3dg.
CC       {ECO:0000269|PubMed:20927107, ECO:0000269|PubMed:7539791}.
CC   -!- INTERACTION:
CC       P30556:AGTR1; NbExp=2; IntAct=EBI-6622938, EBI-6623016;
CC       P25095:Agtr1 (xeno); NbExp=10; IntAct=EBI-751728, EBI-764979;
CC       P50052:AGTR2; NbExp=2; IntAct=EBI-2927577, EBI-1748067;
CC       Q10714:Ance (xeno); NbExp=2; IntAct=EBI-751728, EBI-115736;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- PTM: Beta-decarboxylation of Asp-34 in angiotensin-2, by
CC       mononuclear leukocytes produces alanine. The resulting peptide
CC       form, angiotensin-A, has the same affinity for the AT1 receptor as
CC       angiotensin-2, but a higher affinity for the AT2 receptor.
CC       {ECO:0000269|PubMed:17138938}.
CC   -!- PTM: In response to low blood pressure, the enzyme renin/REN
CC       cleaves angiotensinogen to produce angiotensin-1. Angiotensin-1 is
CC       a substrate of ACE (angiotensin converting enzyme) that removes a
CC       dipeptide to yield the physiologically active peptide angiotensin-
CC       2. Angiotensin-1 and angiotensin-2 can be further processed to
CC       generate angiotensin-3, angiotensin-4. Angiotensin 1-9 is cleaved
CC       from angiotensin-1 by ACE2 and can be further processed by ACE to
CC       produce angiotensin 1-7, angiotensin 1-5 and angiotensin 1-4.
CC       Angiotensin 1-7 has also been proposed to be cleaved from
CC       angiotensin-2 by ACE2 or from angiotensin-1 by MME (neprilysin).
CC       {ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627}.
CC   -!- PTM: The disulfide bond is labile. Angiotensinogen is present in
CC       the circulation in a near 40:60 ratio with the oxidized disulfide-
CC       bonded form, which preferentially interacts with receptor-bound
CC       renin.
CC   -!- DISEASE: Essential hypertension (EHT) [MIM:145500]: A condition in
CC       which blood pressure is consistently higher than normal with no
CC       identifiable cause. {ECO:0000269|PubMed:1394429,
CC       ECO:0000269|PubMed:8513325}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Renal tubular dysgenesis (RTD) [MIM:267430]: Autosomal
CC       recessive severe disorder of renal tubular development
CC       characterized by persistent fetal anuria and perinatal death,
CC       probably due to pulmonary hypoplasia from early-onset
CC       oligohydramnios (the Potter phenotype).
CC       {ECO:0000269|PubMed:16116425}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-10 is the initiator.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=AGT";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Angiotensin entry;
CC       URL="https://en.wikipedia.org/wiki/Angiotensin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02215; AAA51731.1; -; mRNA.
DR   EMBL; M24689; AAA51679.1; -; Genomic_DNA.
DR   EMBL; M24686; AAA51679.1; JOINED; Genomic_DNA.
DR   EMBL; M24687; AAA51679.1; JOINED; Genomic_DNA.
DR   EMBL; M24688; AAA51679.1; JOINED; Genomic_DNA.
DR   EMBL; X15324; CAA33385.1; -; Genomic_DNA.
DR   EMBL; X15325; CAA33385.1; JOINED; Genomic_DNA.
DR   EMBL; X15326; CAA33385.1; JOINED; Genomic_DNA.
DR   EMBL; X15327; CAA33385.1; JOINED; Genomic_DNA.
DR   EMBL; BC011519; AAH11519.1; -; mRNA.
DR   EMBL; M69110; AAA52282.1; -; mRNA.
DR   EMBL; S78529; AAD14287.1; -; Genomic_DNA.
DR   EMBL; S78530; AAD14288.1; -; Genomic_DNA.
DR   CCDS; CCDS1585.1; -.
DR   PIR; A35203; ANHU.
DR   RefSeq; NP_000020.1; NM_000029.3.
DR   UniGene; Hs.19383; -.
DR   PDB; 1N9U; NMR; -; A=34-43.
DR   PDB; 1N9V; NMR; -; A=34-41.
DR   PDB; 2JP8; NMR; -; P=34-40.
DR   PDB; 2WXW; X-ray; 3.30 A; A=34-485.
DR   PDB; 2X0B; X-ray; 4.33 A; B/D/F/H=34-485.
DR   PDB; 3CK0; X-ray; 3.00 A; P=34-41.
DR   PDB; 3WOO; X-ray; 1.80 A; C/D=36-41.
DR   PDB; 3WOR; X-ray; 2.10 A; C/D=34-41.
DR   PDB; 4AA1; X-ray; 1.99 A; P=34-41.
DR   PDB; 4APH; X-ray; 1.99 A; P=34-41.
DR   PDB; 4FYS; X-ray; 2.01 A; C=36-41.
DR   PDB; 5E2Q; X-ray; 2.40 A; B=34-41.
DR   PDBsum; 1N9U; -.
DR   PDBsum; 1N9V; -.
DR   PDBsum; 2JP8; -.
DR   PDBsum; 2WXW; -.
DR   PDBsum; 2X0B; -.
DR   PDBsum; 3CK0; -.
DR   PDBsum; 3WOO; -.
DR   PDBsum; 3WOR; -.
DR   PDBsum; 4AA1; -.
DR   PDBsum; 4APH; -.
DR   PDBsum; 4FYS; -.
DR   PDBsum; 5E2Q; -.
DR   ProteinModelPortal; P01019; -.
DR   SMR; P01019; -.
DR   BioGrid; 106690; 15.
DR   DIP; DIP-309N; -.
DR   IntAct; P01019; 9.
DR   MINT; MINT-1472115; -.
DR   STRING; 9606.ENSP00000355627; -.
DR   ChEMBL; CHEMBL3596085; -.
DR   DrugBank; DB05206; PS433540.
DR   MEROPS; I04.953; -.
DR   iPTMnet; P01019; -.
DR   PhosphoSitePlus; P01019; -.
DR   BioMuta; AGT; -.
DR   DMDM; 113880; -.
DR   SWISS-2DPAGE; P01019; -.
DR   EPD; P01019; -.
DR   MaxQB; P01019; -.
DR   PaxDb; P01019; -.
DR   PeptideAtlas; P01019; -.
DR   PRIDE; P01019; -.
DR   DNASU; 183; -.
DR   Ensembl; ENST00000366667; ENSP00000355627; ENSG00000135744.
DR   GeneID; 183; -.
DR   KEGG; hsa:183; -.
DR   UCSC; uc001hty.6; human.
DR   CTD; 183; -.
DR   DisGeNET; 183; -.
DR   GeneCards; AGT; -.
DR   HGNC; HGNC:333; AGT.
DR   HPA; CAB025798; -.
DR   HPA; HPA001557; -.
DR   MalaCards; AGT; -.
DR   MIM; 106150; gene.
DR   MIM; 145500; phenotype.
DR   MIM; 267430; phenotype.
DR   neXtProt; NX_P01019; -.
DR   OpenTargets; ENSG00000135744; -.
DR   Orphanet; 243761; Essential hypertension.
DR   Orphanet; 97369; Renal tubular dysgenesis of genetic origin.
DR   PharmGKB; PA42; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   eggNOG; COG4826; LUCA.
DR   GeneTree; ENSGT00850000132337; -.
DR   HOVERGEN; HBG004233; -.
DR   InParanoid; P01019; -.
DR   KO; K09821; -.
DR   OMA; RFMQAVT; -.
DR   OrthoDB; EOG091G077M; -.
DR   PhylomeDB; P01019; -.
DR   TreeFam; TF343201; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2022377; Metabolism of Angiotensinogen to Angiotensins.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P01019; -.
DR   ChiTaRS; AGT; human.
DR   EvolutionaryTrace; P01019; -.
DR   GeneWiki; Angiotensin; -.
DR   GenomeRNAi; 183; -.
DR   PMAP-CutDB; P01019; -.
DR   PRO; PR:P01019; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000135744; -.
DR   CleanEx; HS_AGT; -.
DR   ExpressionAtlas; P01019; baseline and differential.
DR   Genevisible; P01019; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; TAS:BHF-UCL.
DR   GO; GO:0005179; F:hormone activity; ISS:BHF-UCL.
DR   GO; GO:0048018; F:receptor agonist activity; IDA:BHF-UCL.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0017080; F:sodium channel regulator activity; IMP:BHF-UCL.
DR   GO; GO:0016176; F:superoxide-generating NADPH oxidase activator activity; TAS:BHF-UCL.
DR   GO; GO:0031702; F:type 1 angiotensin receptor binding; IPI:BHF-UCL.
DR   GO; GO:0031703; F:type 2 angiotensin receptor binding; IPI:BHF-UCL.
DR   GO; GO:0007202; P:activation of phospholipase C activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0002003; P:angiotensin maturation; TAS:Reactome.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0003051; P:angiotensin-mediated drinking behavior; IEA:Ensembl.
DR   GO; GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0001974; P:blood vessel remodeling; TAS:BHF-UCL.
DR   GO; GO:0035411; P:catenin import into nucleus; IEA:Ensembl.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0006883; P:cellular sodium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0050663; P:cytokine secretion; IEA:Ensembl.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0048144; P:fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0007199; P:G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; TAS:BHF-UCL.
DR   GO; GO:0001822; P:kidney development; IMP:BHF-UCL.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; NAS:BHF-UCL.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:BHF-UCL.
DR   GO; GO:0051387; P:negative regulation of neurotrophin TRK receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:2000650; P:negative regulation of sodium ion transmembrane transporter activity; TAS:BHF-UCL.
DR   GO; GO:0034104; P:negative regulation of tissue remodeling; IEA:Ensembl.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; TAS:BHF-UCL.
DR   GO; GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; NAS:BHF-UCL.
DR   GO; GO:0010535; P:positive regulation of activation of JAK2 kinase activity; IMP:UniProtKB.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IDA:UniProtKB.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISS:BHF-UCL.
DR   GO; GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL.
DR   GO; GO:0010873; P:positive regulation of cholesterol esterification; IDA:BHF-UCL.
DR   GO; GO:0001819; P:positive regulation of cytokine production; TAS:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0003331; P:positive regulation of extracellular matrix constituent secretion; IEA:Ensembl.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISS:BHF-UCL.
DR   GO; GO:1903598; P:positive regulation of gap junction assembly; IGI:BHF-UCL.
DR   GO; GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; TAS:BHF-UCL.
DR   GO; GO:1902828; P:positive regulation of L-arginine import into cell; IEA:Ensembl.
DR   GO; GO:1905010; P:positive regulation of L-lysine import into cell; IEA:Ensembl.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IC:BHF-UCL.
DR   GO; GO:1902632; P:positive regulation of membrane hyperpolarization; IMP:BHF-UCL.
DR   GO; GO:0033864; P:positive regulation of NAD(P)H oxidase activity; TAS:BHF-UCL.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:BHF-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IDA:BHF-UCL.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:UniProtKB.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; TAS:BHF-UCL.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IEA:Ensembl.
DR   GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0008217; P:regulation of blood pressure; IGI:BHF-UCL.
DR   GO; GO:0002034; P:regulation of blood vessel diameter by renin-angiotensin; TAS:BHF-UCL.
DR   GO; GO:0002016; P:regulation of blood volume by renin-angiotensin; NAS:BHF-UCL.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:1903779; P:regulation of cardiac conduction; IGI:BHF-UCL.
DR   GO; GO:0001558; P:regulation of cell growth; NAS:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; NAS:BHF-UCL.
DR   GO; GO:1901201; P:regulation of extracellular matrix assembly; IGI:BHF-UCL.
DR   GO; GO:0002027; P:regulation of heart rate; IEA:Ensembl.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl.
DR   GO; GO:0014061; P:regulation of norepinephrine secretion; IEA:Ensembl.
DR   GO; GO:0002019; P:regulation of renal output by angiotensin; NAS:BHF-UCL.
DR   GO; GO:0035813; P:regulation of renal sodium excretion; NAS:BHF-UCL.
DR   GO; GO:0051969; P:regulation of transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:0019229; P:regulation of vasoconstriction; NAS:BHF-UCL.
DR   GO; GO:0003014; P:renal system process; IDA:UniProtKB.
DR   GO; GO:0002018; P:renin-angiotensin regulation of aldosterone production; NAS:BHF-UCL.
DR   GO; GO:0014873; P:response to muscle activity involved in regulation of muscle adaptation; ISS:BHF-UCL.
DR   GO; GO:0048659; P:smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IEA:Ensembl.
DR   GO; GO:0070471; P:uterine smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0042311; P:vasodilation; IEA:Ensembl.
DR   CDD; cd02054; angiotensinogen; 1.
DR   InterPro; IPR000227; Angiotensinogen.
DR   InterPro; IPR033834; Angiotensinogen_serpin.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   PANTHER; PTHR11461; PTHR11461; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   PRINTS; PR00654; ANGIOTENSNGN.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; SSF56574; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Polymorphism;
KW   Reference proteome; Secreted; Signal; Vasoactive; Vasoconstrictor.
FT   SIGNAL        1     33       {ECO:0000269|PubMed:4300938,
FT                                ECO:0000269|PubMed:7259779,
FT                                ECO:0000269|PubMed:7539791}.
FT   CHAIN        34    485       Angiotensinogen.
FT                                /FTId=PRO_0000032456.
FT   PEPTIDE      34     43       Angiotensin-1.
FT                                /FTId=PRO_0000032457.
FT   PEPTIDE      34     42       Angiotensin 1-9.
FT                                /FTId=PRO_0000420659.
FT   PEPTIDE      34     41       Angiotensin-2.
FT                                /FTId=PRO_0000032458.
FT   PEPTIDE      34     40       Angiotensin 1-7.
FT                                /FTId=PRO_0000420660.
FT   PEPTIDE      34     38       Angiotensin 1-5.
FT                                /FTId=PRO_0000420661.
FT   PEPTIDE      34     37       Angiotensin 1-4.
FT                                /FTId=PRO_0000420662.
FT   PEPTIDE      35     41       Angiotensin-3.
FT                                /FTId=PRO_0000032459.
FT   PEPTIDE      36     41       Angiotensin-4.
FT                                /FTId=PRO_0000420663.
FT   MOD_RES      34     34       Beta-decarboxylated aspartate; in form
FT                                angiotensin-A.
FT                                {ECO:0000269|PubMed:17138938}.
FT   CARBOHYD     47     47       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:3934016}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3934016}.
FT   CARBOHYD    304    304       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3934016}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3934016}.
FT   DISULFID     51    171       {ECO:0000269|PubMed:20927107}.
FT   VARIANT      43     43       L -> F (associated with susceptibility to
FT                                pre-eclampsia; alters the reactions with
FT                                renin and angiotensin-converting enzyme;
FT                                dbSNP:rs41271499).
FT                                {ECO:0000269|PubMed:7744780}.
FT                                /FTId=VAR_022933.
FT   VARIANT      98     98       E -> K (in dbSNP:rs11568032).
FT                                /FTId=VAR_029166.
FT   VARIANT     114    114       G -> C (in dbSNP:rs2229389).
FT                                /FTId=VAR_051939.
FT   VARIANT     137    137       T -> M (in dbSNP:rs34829218).
FT                                /FTId=VAR_035431.
FT   VARIANT     207    207       T -> M (associated with hypertension;
FT                                dbSNP:rs4762).
FT                                {ECO:0000269|PubMed:1394429}.
FT                                /FTId=VAR_007093.
FT   VARIANT     242    242       T -> I (associated with susceptibility to
FT                                hypertension; dbSNP:rs765678426).
FT                                {ECO:0000269|PubMed:7607642}.
FT                                /FTId=VAR_007094.
FT   VARIANT     244    244       L -> R (associated with susceptibility to
FT                                hypertension; dbSNP:rs5041).
FT                                {ECO:0000269|PubMed:7607642}.
FT                                /FTId=VAR_007095.
FT   VARIANT     268    268       M -> I (in dbSNP:rs11568053).
FT                                /FTId=VAR_029167.
FT   VARIANT     268    268       M -> T (associated with essential
FT                                hypertension and pre-eclampsia;
FT                                dbSNP:rs699).
FT                                {ECO:0000269|PubMed:1394429,
FT                                ECO:0000269|PubMed:8513325}.
FT                                /FTId=VAR_007096.
FT   VARIANT     281    281       Y -> C (associated with susceptibility to
FT                                hypertension; alters the structure,
FT                                glycosylation and secretion of
FT                                angiotensinogen; dbSNP:rs56073403).
FT                                {ECO:0000269|PubMed:1394429,
FT                                ECO:0000269|PubMed:7607642,
FT                                ECO:0000269|PubMed:8621667}.
FT                                /FTId=VAR_007097.
FT   VARIANT     335    335       P -> S (in dbSNP:rs17856352).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_035432.
FT   VARIANT     375    375       R -> Q (in RTD; dbSNP:rs74315283).
FT                                {ECO:0000269|PubMed:16116425}.
FT                                /FTId=VAR_035433.
FT   VARIANT     392    392       L -> M (in dbSNP:rs1805090).
FT                                /FTId=VAR_014573.
FT   CONFLICT     51     51       C -> S (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     58     58       N -> D (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    333    333       Q -> E (in Ref. 2; AAA51679).
FT                                {ECO:0000305}.
FT   TURN         42     44       {ECO:0000244|PDB:2WXW}.
FT   HELIX        48     57       {ECO:0000244|PDB:2WXW}.
FT   STRAND       59     62       {ECO:0000244|PDB:2WXW}.
FT   HELIX        81     93       {ECO:0000244|PDB:2WXW}.
FT   HELIX        97    117       {ECO:0000244|PDB:2WXW}.
FT   HELIX       118    120       {ECO:0000244|PDB:2WXW}.
FT   TURN        124    126       {ECO:0000244|PDB:2WXW}.
FT   STRAND      129    134       {ECO:0000244|PDB:2WXW}.
FT   HELIX       136    148       {ECO:0000244|PDB:2WXW}.
FT   HELIX       154    162       {ECO:0000244|PDB:2WXW}.
FT   TURN        171    173       {ECO:0000244|PDB:2WXW}.
FT   HELIX       177    191       {ECO:0000244|PDB:2WXW}.
FT   TURN        195    197       {ECO:0000244|PDB:2WXW}.
FT   STRAND      203    212       {ECO:0000244|PDB:2WXW}.
FT   HELIX       221    230       {ECO:0000244|PDB:2WXW}.
FT   STRAND      234    236       {ECO:0000244|PDB:2WXW}.
FT   HELIX       244    259       {ECO:0000244|PDB:2WXW}.
FT   STRAND      277    288       {ECO:0000244|PDB:2WXW}.
FT   STRAND      291    293       {ECO:0000244|PDB:2WXW}.
FT   STRAND      302    305       {ECO:0000244|PDB:2WXW}.
FT   STRAND      313    322       {ECO:0000244|PDB:2WXW}.
FT   TURN        325    328       {ECO:0000244|PDB:2WXW}.
FT   STRAND      329    333       {ECO:0000244|PDB:2WXW}.
FT   TURN        337    339       {ECO:0000244|PDB:2WXW}.
FT   STRAND      340    349       {ECO:0000244|PDB:2WXW}.
FT   HELIX       353    358       {ECO:0000244|PDB:2WXW}.
FT   HELIX       365    368       {ECO:0000244|PDB:2WXW}.
FT   STRAND      374    381       {ECO:0000244|PDB:2WXW}.
FT   STRAND      385    391       {ECO:0000244|PDB:2WXW}.
FT   HELIX       392    395       {ECO:0000244|PDB:2WXW}.
FT   HELIX       402    406       {ECO:0000244|PDB:2WXW}.
FT   STRAND      407    409       {ECO:0000244|PDB:2WXW}.
FT   STRAND      425    434       {ECO:0000244|PDB:2WXW}.
FT   STRAND      452    455       {ECO:0000244|PDB:2WXW}.
FT   STRAND      460    466       {ECO:0000244|PDB:2WXW}.
FT   TURN        467    470       {ECO:0000244|PDB:2WXW}.
FT   STRAND      475    479       {ECO:0000244|PDB:2WXW}.
SQ   SEQUENCE   485 AA;  53154 MW;  5026C2DFB2DD236E CRC64;
     MRKRAPQSEM APAGVSLRAT ILCLLAWAGL AAGDRVYIHP FHLVIHNEST CEQLAKANAG
     KPKDPTFIPA PIQAKTSPVD EKALQDQLVL VAAKLDTEDK LRAAMVGMLA NFLGFRIYGM
     HSELWGVVHG ATVLSPTAVF GTLASLYLGA LDHTADRLQA ILGVPWKDKN CTSRLDAHKV
     LSALQAVQGL LVAQGRADSQ AQLLLSTVVG VFTAPGLHLK QPFVQGLALY TPVVLPRSLD
     FTELDVAAEK IDRFMQAVTG WKTGCSLMGA SVDSTLAFNT YVHFQGKMKG FSLLAEPQEF
     WVDNSTSVSV PMLSGMGTFQ HWSDIQDNFS VTQVPFTESA CLLLIQPHYA SDLDKVEGLT
     FQQNSLNWMK KLSPRTIHLT MPQLVLQGSY DLQDLLAQAE LPAILHTELN LQKLSNDRIR
     VGEVLNSIFF ELEADEREPT ESTQQLNKPE VLEVTLNRPF LFAVYDQSAT ALHFLGRVAN
     PLSTA
//
